Understand what your brain mood hormones supplements results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
How much to take, which form, and when
Take 300 to 600 mg of a standardized root extract daily, matched to your goal:
| Goal | Extract | Daily dose | Timing | Trial length |
|---|---|---|---|---|
| Stress and cortisol | KSM-66 | 300-600 mg (2022 meta-analysis) | Morning, or split morning and evening | 8 weeks |
| Sleep quality | Root extract | 600 mg, as 300 mg twice daily (2019 RCT) | Evening | 10 weeks |
| Testosterone in men | KSM-66 | 600 mg | Once daily or split | 8 weeks |
Form
The two leading extracts, KSM-66 and Sensoril, differ in withanolide profile and in the outcomes they've been tested for. Generic ashwagandha powders or non-standardized capsules are not interchangeable with these extracts and should not be expected to produce the same results.
Dose
How much is too much isn't well defined: safety trials in healthy adults have tested 125 to 600 mg daily for up to 180 days (2026 systematic review), so there is little long-term safety data to support going higher. Most sleep trials have used 600 mg a day (2021 meta-analysis). Higher doses have been tested for safety without showing additional benefit for stress outcomes, though they may be relevant for other applications. A gradual approach, starting at a lower dose and adjusting based on response, is commonly recommended.
Timing
Ashwagandha can be taken in the morning, evening, or split between both, depending on your cortisol pattern and symptoms:
- Split dosing (300 mg in the morning and 300 mg before bed) may address both ends of the cortisol curve.
- Taking it with or without food doesn't significantly affect absorption, though some users report less GI upset when taken with meals.
Combinations
Ashwagandha is often combined with other adaptogens like rhodiola or holy basil, but there's no clinical evidence that these combinations are more effective than ashwagandha alone. If you're taking magnesium for sleep or stress, the two can be taken together without interaction. Avoid combining ashwagandha with sedative medications or other GABAergic compounds without medical guidance, as the effects may be additive. If you're on thyroid medication, monitor thyroid function closely, as ashwagandha can increase thyroid hormone levels in some individuals.
What ashwagandha is and how standardized extracts differ
Ashwagandha is an adaptogenic herb from the root of Withania somnifera, used in Ayurvedic medicine for centuries. Its bioactive compounds, called withanolides, are responsible for most of its physiological effects. The concentration and profile of these withanolides vary dramatically depending on how the root is extracted and processed, which is why not all ashwagandha supplements behave the same way in the body.
Two proprietary extracts dominate the clinical literature:
- KSM-66 is a full-spectrum root extract standardized to at least 5% withanolides, produced through a water-based extraction process that preserves the natural ratio of compounds found in the whole root.
- Sensoril is extracted from both roots and leaves and standardized to a higher withanolide concentration (typically 10%), with a specific focus on withaferin A.
- KSM-66 has been studied primarily for stress reduction, endurance, testosterone support in men, and cognitive performance.
- Sensoril has been tested more often in studies targeting metabolic outcomes and body composition.
The distinction matters because the withanolide profile influences which pathways are activated. KSM-66's full-spectrum approach may offer broader adaptogenic effects, while Sensoril's higher withaferin A content may produce more pronounced effects on inflammation and metabolic signaling. Generic ashwagandha powders or capsules that don't specify standardization or extraction method are unlikely to deliver the same results seen in clinical trials, because withanolide content can vary from less than 1% to over 10% depending on growing conditions, harvest timing, and processing.
What the clinical trials show on stress, cortisol, and sleep
The evidence for ashwagandha's effects on stress and cortisol is stronger than for most herbal adaptogens, but it's not uniform across all populations or outcomes. A 2019 randomized controlled trial of KSM-66 found significant reductions in perceived stress scores and morning cortisol levels compared to placebo in adults with chronic stress. The cortisol reduction was modest but consistent, averaging around 25% from baseline. Importantly, the effect was most pronounced in individuals who started with elevated cortisol, not in those with normal baseline levels.
For sleep, the evidence is more mixed. A 2020 study of ashwagandha root extract showed improvements in sleep quality, sleep onset latency, and total sleep time in adults with insomnia, but the effect size was moderate and not all participants responded. The mechanism here isn't direct sedation but rather a reduction in nighttime cortisol and an improvement in HPA axis regulation, which indirectly supports better sleep architecture.
Studies on anxiety show similar patterns. A meta-analysis of five RCTs found that ashwagandha significantly reduced anxiety scores compared to placebo, but the trials were small, heterogeneous in dosing, and often conducted in populations with subclinical anxiety rather than diagnosed anxiety disorders. The anxiolytic effect is mechanistically plausible through NMDA receptor modulation and GABAergic activity.
For cognitive performance, the data is thinner. A few small trials using KSM-66 or magnesium L-threonate combined with ashwagandha have shown improvements in memory and reaction time, but these findings need replication in larger, well-controlled studies. The cognitive effects are likely secondary to stress reduction rather than direct nootropic action. One critical limitation across the literature is that most trials are industry-funded, short-term (8 to 12 weeks), and conducted in relatively healthy adults.
How ashwagandha modulates the HPA axis and cortisol rhythm
Ashwagandha doesn't just lower cortisol; it modulates the hypothalamic-pituitary-adrenal axis, the body's central stress response system. Under chronic stress, the HPA axis becomes hyperreactive, leading to elevated morning cortisol, blunted cortisol awakening response, and disrupted diurnal rhythm. Withanolides appear to dampen this overactivation through several pathways.
First, they act on GABA-A receptors in the brain, enhancing inhibitory neurotransmission and reducing excitatory tone. This is similar to how benzodiazepines work, but with far weaker affinity and no risk of dependence. Second, withanolides influence glucocorticoid receptor sensitivity, which affects how cells respond to cortisol signaling. When the HPA axis is chronically activated, glucocorticoid receptors can become desensitized, leading to a state where cortisol is elevated but less effective. Ashwagandha may help restore receptor sensitivity, allowing the body to respond appropriately to stress without overproducing cortisol.
Third, ashwagandha affects the balance between cortisol and DHEA-S, an adrenal androgen that counteracts some of cortisol's catabolic effects. Studies show that ashwagandha supplementation can reduce the cortisol-to-DHEA-S ratio, which is associated with improved stress resilience and recovery (2019 rct).
The timing of these effects matters. Cortisol follows a natural diurnal rhythm, peaking within 30 minutes of waking and declining throughout the day to reach its lowest point at night. Chronic stress flattens this curve, leading to elevated evening cortisol and disrupted sleep. Ashwagandha's effect on cortisol rhythm is most evident in the morning (where it reduces the exaggerated cortisol spike seen in stressed individuals) and in the evening (where it helps restore the natural decline).
Who responds best and who should exercise caution
Ashwagandha's effects are most pronounced in individuals with elevated baseline cortisol, chronic stress, or subclinical anxiety. If your cortisol is already in the normal range and you're not experiencing significant stress, the benefit is likely to be minimal. This is a repletion effect, not a pharmacological one. The supplement is correcting a dysregulated HPA axis, not enhancing a system that's already functioning well.
Men with low testosterone may see modest improvements, particularly if low testosterone is stress-related rather than primary hypogonadism. A 2019 study of KSM-66 in overweight men showed a 15% increase in testosterone, but this was in the context of weight loss and improved body composition. Women with PCOS or elevated androgens should use caution, as ashwagandha can increase testosterone and DHEA-S, potentially worsening symptoms.
Older adults may benefit from ashwagandha's effects on muscle strength and recovery, but they should also be monitored for interactions with medications, particularly those affecting thyroid function, blood pressure, or blood sugar. Ashwagandha can lower blood glucose and blood pressure, which may require dose adjustments in medications for diabetes or hypertension.
Specific populations should avoid or use extreme caution with ashwagandha:
- Pregnant and breastfeeding women should avoid ashwagandha, as there is insufficient safety data and some animal studies suggest potential effects on fetal development (2025 systematic review).
- Individuals with autoimmune thyroid conditions (particularly Hashimoto's thyroiditis) should use caution, as ashwagandha can increase thyroid hormone production and may exacerbate autoimmune activity in some cases.
- Those with Graves' disease or hyperthyroidism should not take ashwagandha.
- Liver function should be monitored during prolonged use, as there have been case reports of elevated liver enzymes and hepatotoxicity associated with ashwagandha supplementation.
- If you're taking medications metabolized by CYP3A4 enzymes, ashwagandha may alter drug levels, and medical supervision is warranted.
Cycling, tolerance, and whether you need to take breaks
The question of whether to cycle ashwagandha is not settled by the clinical literature, because most studies run for 8 to 12 weeks and don't assess what happens with continuous use beyond that. The rationale for cycling is based on the concern that the body may adapt to the HPA axis modulation, reducing the supplement's effectiveness over time. This is plausible but not proven.
Some practitioners recommend a 2-weeks-on, 1-week-off cycle, or a 3-months-on, 1-month-off cycle, to prevent tolerance. The logic is that taking periodic breaks allows the HPA axis to reset and prevents downregulation of the receptors ashwagandha acts on. However, there's no direct evidence that tolerance develops with continuous use, and some users report sustained benefits for six months or longer without cycling.
If you've been taking ashwagandha for several months and notice diminishing effects, a break of two to four weeks is reasonable to assess whether the benefit returns. If it does, that suggests some degree of tolerance had developed. If it doesn't, the initial benefit may have been placebo or the underlying stressor may have resolved.
Another reason to cycle is to reassess whether you still need it. Ashwagandha is not a long-term solution to chronic stress; it's a tool to support the body while you address the root causes. If you've been taking it for three months and your stress levels haven't improved, the issue may not be cortisol dysregulation but something else entirely (like sleep deprivation, poor nutrition, or unresolved psychological stressors).
Test 100+ biomarkers
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers
One blood draw. A full picture of your health, explained in plain language.
Side effects, interactions, and what to watch for
Ashwagandha is well tolerated in most clinical trials, but side effects do occur:
- The most common are gastrointestinal (including nausea, diarrhea, and stomach upset), particularly at higher doses or when taken on an empty stomach.
- Drowsiness is another reported side effect, particularly when taken during the day, and is more common with evening dosing but can occur in sensitive individuals at any time.
- Thyroid function changes are a more serious concern, as ashwagandha can increase T3 and T4 levels (beneficial in subclinical hypothyroidism but problematic in individuals with normal or elevated thyroid function).
- Liver enzyme elevation has been reported in a small number of cases, some of which progressed to clinical hepatotoxicity.
If you're on thyroid medication, monitor TSH, free T3, and free T4 regularly, as dose adjustments may be needed. If you have hyperthyroidism or Graves' disease, do not take ashwagandha. Monitor liver function if you're taking ashwagandha long-term, particularly at doses above 600 mg daily or in combination with other supplements or medications that stress the liver (2025 rct).
Ashwagandha may interact with immunosuppressants, as it has mild immune-stimulating effects. If you're on medications for autoimmune conditions or post-transplant, consult your physician before starting ashwagandha. It may also potentiate the effects of sedatives, benzodiazepines, and other CNS depressants.
Testing cortisol to see whether it's working
Symptom relief is an incomplete measure, because subjective stress scores don't always track objective HPA axis function. Morning cortisol, measured within 30 minutes of waking, is the most informative single time point, and a four-point salivary test (waking, midday, evening, and bedtime) maps the full daily curve. DHEA-S adds context: a high cortisol-to-DHEA-S ratio suggests chronic stress, and ashwagandha has been shown to reduce this ratio in clinical trials (2019 rct). Check TSH, free T3, and free T4 at baseline and after 3 months, plus hs-CRP for low-grade inflammation. Superpower's 100+ biomarker panel includes cortisol, DHEA-S, thyroid function, and inflammatory markers. Testing before you start and again after 3 months shows whether the supplement is working and whether your dose needs adjustment.
Frequently Asked Questions
References
- Kelaiditis CF, Gibson EL, Dyall SC (2022). Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials. https://doi.org/10.1101/2022.10.17.22281092
- Lopresti AL, Smith SJ, Malvi H, Kodgule R (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. *Medicine*, *98*(37), e17186. https://doi.org/10.1097/MD.0000000000017186
- Akhgarjand C, Asoudeh F, Bagheri A, Kalantar Z, Vahabi Z, Shab-Bidar S, Rezvani H, Djafarian K (2022). Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. *Phytotherapy research : PTR*, *36*(11), 4115-4124. https://doi.org/10.1002/ptr.7598
- Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D (2019). Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. *Cureus*, *11*(9), e5797. https://doi.org/10.7759/cureus.5797
- Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R (2021). Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. *PloS one*, *16*(9), e0257843. https://doi.org/10.1371/journal.pone.0257843
- Coope OC, Willems MET, Levington A, Tallon MJ, Roman-Viñas B, Spurr TJ (2026). Back to the Roots: Safety and Tolerability of Standardised Ashwagandha (Withania somnifera) Root Extract in Healthy Adults-A Systematic Review of Biomarkers and Adverse Events. *Pharmaceuticals (Basel, Switzerland)*, *19*(5), 725. https://doi.org/10.3390/ph19050725
- Tallon MJ, Koturbash I, Blum JL (2025). A Systematic and Ethnobotanical Review of Ashwagandha's (Withania Somnifera) Teratogenic and Abortifacient Potentials. *Phytotherapy research : PTR*. https://doi.org/10.1002/ptr.70079
- Mallinson PAC, Joshi M, Mathpathi M, Perkins A, Clayton T, Shah AS, Mathur R, Birk N, Dhillon A, Lieber J, Beg SS, Hopkins L, Khan A, Allaham S, Kam VT, Sutaria S, R G, Rajagopala S, Bhamra A, ... Kinra S (2025). Ashwagandha (. *BMJ open*, *15*(4), e094526. https://doi.org/10.1136/bmjopen-2024-094526
- Lopresti AL, Drummond PD, Smith SJ (2019). A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males. *American journal of men's health*, *13*(2), 1557988319835985. https://doi.org/10.1177/1557988319835985



















